Background Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical
cohort studies of different populations are important to understand the high variability in …

Biomarkers in sarcoidosis: the contribution of system biolog... : Current Opinion in
Pulmonary Medicine Biomarkers in sarcoidosis: the contribution of system biology : Current …

Insights into triggering immune events and susceptibility genes should provide potential new
strategies and targets for therapy. The judicious use of MRI in suspected cases can enhance …

Sarcoidosis is a systemic granulomatous disorder of unknown etiology, with a predilection
for the respiratory system, involved in more than 90% of cases, with considerable variability …

Sarcoidosis is a highly variable granulomatous multisystem syndrome. It affects individuals
in the prime years of life; both the frequency and severity of sarcoidosis are greater in …

Sarcoidosis is a complex granulomatous disease of unknown cause. Corticosteroids and
immune suppressants are often given long term in chronic disease, which may result in …

Sarcoidosis, a systemic granulomatous disease of undetermined etiology, is characterized
by a variable clinical presentation and course. During the past decade, advances have been …

Sarcoidosis is a chronic granulomatous inflammatory disease of unknown etiology with
heterogeneous outcome. Based on the natural history or clinical treatment course, the …

Sarcoidosis is a multisystem granulomatous disease with large variability in presentation,
disease behavior, and outcome. The cause of sarcoidosis and explanation for its wide …

Sarcoidosis is one in a heterogeneous family of granulomatous disorders. The clinical
manifestations of sarcoidosis can vary widely, depending on the patient and the tissues …